BIOL 2020 Lecture Notes - Lecture 31: Medical Guideline, Speakers Bureau, Pharmacy School
22 May 2020
School
Department
Course
Professor
Document Summary
Pharmacists must maintain a strong commitment to use evidence-based evaluations in developing drug use guidelines and strive to achieve optimal outcomes. Once again, disclosure of all relationships with industry should be mandatory for all participants involved in developing the practice guideline, and the potential conflicts of interest should be published as a component of the practice guideline. Pharmacists who are members of an institutional review board (irb) should avoid any real, potential, or perceived conflicts of interest that could occur in connection with industry-related matters before the irb. Explanation: there are specific federal regulations governing membership of irbs. 52 the. Irb is also required to ensure its members do not have conflicts of interests that would impair their ability to make a fair and reasonable judgment concerning a protocol under review. Pharmacists participating as a member of an irb should assess research protocols, drug therapy, and patient risk in a fair and unbiased manner.
